我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

参附注射液治疗脓毒症休克:基于临床实践与科学研究的思考(PDF)

《医学争鸣》[ISSN:1000-2790/CN:61-1060/R]

期数:
2019年05期
页码:
52-54
栏目:
学术探讨
出版日期:
2019-10-31

文章信息/Info

Title:
Shenfu injection in the treatment of septic shock: thoughts based on clinical practice and scientific research
作者:
范荣荣1李 燕2张忠德2刘云涛2
(1广州中医药大学第二临床医学院,广东 广州 510504;2广东省中医院,广东 广州 510120)
Author(s):
FAN Rongrong1 LI Yan2 ZHANG Zhongde2 LIU Yuntao2
1 Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510504, China; 2 Guangdong Province Hospital of Chinese Medicine, Guangzhou 510120, China
关键词:
参附注射液脓毒症休克中医
Keywords:
Shenfu injection septic shock traditional Chinese medicine
分类号:
R278
DOI:
10.13276/j.issn.1674-8913.2019.05.014
文献标识码:
A
摘要:
参附注射液被广泛用于治疗脓毒症休克,相关的临床研究也很多,但缺乏使用规范。最新Meta分析 结果显示参附注射液对脓毒症休克最终结局指标——28 d死亡率无影响,笔者认为这与参附注射液治疗脓毒性休 克的适应人群、干预剂量及干预疗程等没有统一规范和标准有关,今后的临床研究应该围绕这些问题开展,为临 床用药提供依据。
Abstract:
Shenfu injection has been widely used in China for the treatment of septic shock. There are many clinical studies about Shenfu injection used for the treatment of septic shock, but its use has not been standardized. A newly published Meta-analysis suggested that Shenfu injection did not improve the 28-day mortality, a final indicator of outcomes of septic shock. We believe that this is related to a lack of unified standard for suitable population, intervention dose and intervention course. Future clinical researches should focus on these questions in order to provide evidence for clinical practice.

参考文献/References

[1] 郭秀芹, 孔 立, 范开亮, 等. 参附注射液治疗脓毒症休 克研究进展[J]. 新中医, 2017, 49(6):143-145.
[2] Zhang N, Liu J, Qiu Z, et al. Shenfu injection for improving cellular immunity and clinical outcome in patients with sepsis or septic shock[J]. Am J Emerg Med, 2017, 35(1):1-6.
[3] 奚小土, 朱满刚, 刘云涛, 等. 参附注射液对脓毒症 患者免疫功能、炎症指标的影响[J]. 新中医, 2018, 50(6):72-76.
[4] 陶婉君, 李 根, 杨 卓. 参附注射液用于成人脓毒性休克患者早期复苏的Meta分析[J]. 药物流行病学杂志, 2018, 27(3):152-156.
[5] Li Y, Zhang X, Lin P, et al. Effects of Shenfu injection in the treatment of septic shock patients: a multicenter, controlled, randomized, open-label trial[J]. Evid Based Complement Alternat Med, 2016:2565169.
[6] 中国中西医结合学会急救医学专业委员会. 脓毒症中西 医结合诊治专家共识[C]. 天津:2008.
[7] 林新峰. 生脉注射液、参附注射液治疗厥脱症的比较研 究[J]. 安徽中医临床杂志, 2002, 14(2):80-82.
[8] Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016[J]. Intensive Care Med, 2017, 43(3):304-377.
[9] 范荣荣. 脓毒症致MODS发病态势中证候要素的阶段性 特征研究[D]. 广州:广州中医药大学, 2013.
[10] 李 菁. 脓毒症中医证型与乳酸值、SIRS分值的相关性 研究[D]. 福州:福建中医药大学, 2017.
[11] 高晓山. 中药药性论[M]. 北京:人民卫生出版社, 1992, 83-113.
[12] 许国振. 古今中药剂量换算的考证[J]. 中医文献杂志, 2010(2):23-24.
[13] Mou ZJ, Lv ZT, Li Y, et al. Clinical effect of Shenfu injection in patients with septic shock: a meta-analysis and systematic review[J]. Evid Based Complement Alternat Med, 2015:863149.
[14] Wu W, Jiang RL, Wang LC, et al. Effect of Shenfu injection on intestinal mucosal barrier in a rat model of sepsis[J]. Am J Emerg Med, 2015, 33(9):1237-1243.
[15] 张 圆, 任长虹, 吴晓丹, 等. 参附注射液的临床应用及临 床机制研究进展[J]. 药物评价研究, 2018, 41(6):1141-1146.

备注/Memo

备注/Memo:
基金项目:广东省科技计划项目(2013B021800238);广东省中医院中医药科学技术研究专项(YN2018ZD03)
通信作者:刘云涛。Tel:020-81887233,E-mail:iamliuyuntao@163.com
作者简介:范荣荣。博士生(导师张忠德)。研究方向:中医药治疗呼吸及急危重症研究。Tel:13560041790, E-mail:370087677@qq.com
更新日期/Last Update: 2019-10-31